15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 2.2% per year over the past 5 years.
Net income has grown faster than revenue (3.4% vs 2.2% per year).
Operating margin has expanded, at 22.3% in the latest year.
Free cash flow has grown 6.9% per year over the past 5 years.
Financial health
Total debt ($1.7B) exceeds cash ($839M); net debt is $815M.
Total debt has grown slower than revenue (-3.0% vs 2.2% per year).
Operating income covered interest expense 14× in the latest year.
Total debt is 2.5× EBITDA.
Shareholder returns
Dividends have been paid for 1 consecutive year, consuming 12.8% of earnings and 12.0% of free cash flow.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$2.1B
$425M
62.2%
22.3%
$453M
$1.7B
$839M
2024
$2.0B
$84M
48.9%
4.9%
$506M
$1.4B
$664M
2023
$2.0B
$341M
62.8%
20.9%
$310M
$1.5B
$668M
2022
$2.1B
$423M
64.7%
24.8%
$586M
$1.9B
$731M
2021
$2.3B
$513M
64.4%
28.0%
$449M
$1.9B
$881M
2020
$1.9B
$359M
65.9%
20.7%
$325M
$1.9B
$598M
2019
$1.5B
-$41M
65.9%
-1.7%
$213M
$1.7B
$624M
2018
$1.5B
$190M
66.6%
17.8%
$250M
$2.2B
$1.2B
2017
$1.4B
$40M
65.1%
10.8%
$197M
$1.8B
$658M
2016
$1.3B
$80M
63.1%
7.4%
$267M
$1.1B
$439M
2015
—
$130M
—
—
$220M
$1.0B
$290M
2014
—
$116M
—
—
$201M
$1.2B
$393M
2013
—
$69M
—
—
$174M
$845M
$330M
2012
—
$130M
—
—
$143M
$847M
$394M
2011
—
$96M
—
—
$158M
$590M
$221M
Valuation over time
How the market has priced QGEN against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 23.7× (Mar '23) to 20.1× (Jun '26).
The price-to-sales ratio has fallen from 4.7× (Mar '23) to 4.1× (Jun '26).
The dividend yield has risen from 0.6% (Dec '25) to 0.6% (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is QGEN growing its revenue and profit?
Over the past 5 years, Qiagen N.V.'s revenue has grown 2.2% per year, and net income grown 3.4% per year. These are computed facts, not advice.
How much debt does QGEN have?
As of FY2025, Qiagen N.V. reported $1.7B of total debt against $839M of cash; operating income covered interest expense 14×.
What is QGEN's profit margin?
In FY2025, gross margin was 62.2%, operating margin 22.3%, and net margin 20.3%.
What is QGEN's P/E ratio?
As of Jun '26, Qiagen N.V. traded at a price-to-earnings ratio of about 20.1× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.